CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase

Charcot–Marie–Tooth diseases are hereditary peripheral neuropathies for which there are currently no effective therapies; here the type 2D subtype of these diseases is shown to be caused by mutations impeding a signalling pathway necessary for motor neuron survival.